News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,135 Results
Type
Article (88891)
Company Profile (747)
Press Release (795475)
Multimedia
Podcasts (243)
Webinars (35)
Section
Business (233641)
Career Advice (4164)
Deals (40015)
Drug Delivery (181)
Drug Development (91761)
Employer Resources (207)
FDA (18583)
Job Trends (17494)
News (398844)
Policy (40020)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (210)
Alliances (56990)
ALS (242)
Alzheimer's disease (1989)
Antibody-drug conjugate (ADC) (578)
Approvals (18970)
Artificial intelligence (900)
ASCO (345)
Autoimmune disease (378)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (76)
BIOSECURE Act (23)
Biosimilars (254)
Biotechnology (443)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (855)
Cancer (6734)
Cardiovascular disease (568)
Career advice (3601)
Career pathing (53)
CAR-T (392)
CDC (77)
Celiac Disease (3)
Cell therapy (1098)
Cervical cancer (58)
Clinical research (79287)
Collaboration (2435)
Commercialization (1)
Company closure (8)
Compensation (1546)
Complete response letters (108)
COVID-19 (3044)
CRISPR (128)
C-suite (1328)
Cystic fibrosis (168)
Data (8904)
Decentralized trials (3)
Denatured (93)
Depression (200)
Dermatology (100)
Diabetes (718)
Diagnostics (7628)
Digital health (72)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (453)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (328)
Earnings (102529)
Editorial (80)
Employer branding (25)
Employer resources (177)
Events (138912)
Executive appointments (1214)
FDA (22799)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2006)
Gene editing (278)
Generative AI (91)
Gene therapy (864)
GLP-1 (1294)
Government (5570)
Grass and pollen (8)
Guidances (425)
Healthcare (21271)
Hematology (198)
HIV (100)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (116)
Immunology and inflammation (363)
Immuno-oncology (119)
Indications (223)
Infectious disease (3452)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (331)
Interviews (822)
IPO (18009)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (126)
Layoffs (694)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (888)
Lymphoma (488)
Machine learning (70)
Management (68)
Manufacturing (1280)
Marketing (4)
MASH (229)
Medical affairs (1)
Medical device (15301)
Medtech (15484)
Mergers & acquisitions (23339)
Metabolic disorders (1857)
mRNA (275)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (525)
Neuropsychiatric disorders (131)
Neuroscience (3791)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (83)
Obesity (884)
Opinion (380)
Ovarian cancer (250)
Pain (288)
Pancreatic cancer (372)
Parkinson's disease (428)
Partnered (42)
Patents (676)
Patient recruitment (806)
Peanut (72)
People (68136)
Pharmaceutical (118)
Pharmacy benefit managers (38)
Phase 1 (24504)
Phase 2 (34446)
Phase 3 (25895)
Pipeline (10158)
Policy (405)
Postmarket research (3560)
Preclinical (11001)
Press Release (72)
Prostate cancer (354)
Psychedelics (73)
Radiopharmaceuticals (378)
Rare diseases (1316)
Real estate (7462)
Recruiting (82)
Regulatory (30598)
Reports (77)
Research institute (2776)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (344)
Series B (250)
Service/supplier (26)
Sickle cell disease (130)
Special edition (33)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4375)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (147)
Vaccines (1328)
Venture capital (142)
Weight loss (603)
Women's health (147)
Worklife (25)
Date
Today (148)
Last 7 days (542)
Last 30 days (2651)
Last 365 days (33166)
2026 (17568)
2025 (33217)
2024 (38054)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52398)
Australia (9208)
California (14600)
Canada (4099)
China (1626)
Colorado (629)
Connecticut (649)
Delaware (452)
Europe (120828)
Florida (2189)
Georgia (474)
Hawaii (4)
Idaho (70)
Illinois (1283)
India (107)
Indiana (672)
Iowa (27)
Japan (621)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1762)
Massachusetts (10699)
Michigan (427)
Minnesota (817)
Mississippi (7)
Missouri (166)
Montana (37)
Nebraska (31)
Nevada (156)
New Hampshire (92)
New Jersey (3872)
New Mexico (35)
New York (3858)
North Carolina (1957)
North Dakota (11)
Northern California (7282)
Ohio (456)
Oklahoma (27)
Oregon (55)
Pennsylvania (2865)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5741)
Tennessee (239)
Texas (2389)
United States (52265)
Utah (435)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 885,135 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivotal study for Amgen’s rare disease drug Tavneos, which has been in the FDA’s crosshairs since January.
July 1, 2026
·
2 min read
·
Jef Akst
Job Trends
Opinion: Innovation wins the contract. Complexity loses the renewal
Innovation drives CROs to win new business, but unchecked customization creates complexity that undermines reproducibility, weakens renewals and leads to turnover—making standardization a strategic necessity, not a constraint.
July 1, 2026
·
3 min read
·
Antonio Serrano
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
The U.K.’s core biotech cluster continues to produce world‑class science, but investors say limited talent mobility, uneven regional growth and tightening early‑ and mid‑stage capital are slowing the country’s ability to scale new companies.
July 1, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Job Trends
Opinion: The life sciences executive search crisis: When “cutting to the bone” backfires
The 2022 search approach is no longer working. Companies need to think critically about how they are acquiring top regulatory, clinical and commercial executives or risk their programs in this new regulatory and market reality.
July 1, 2026
·
6 min read
·
Emma Morris
Mergers & acquisitions
Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend
The total of 52 mergers and acquisitions for the first half of 2026 reflects what analysts, industry watchers and executives are saying over and over: M&A is back.
July 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Orca Bio’s TREGZI™ Receives U.S. FDA Approval as First and Only Precision-Engineered Cell Therapy for Allogeneic Transplant in Adults with Hematological Malignancies
July 1, 2026
·
9 min read
Press Releases
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
July 1, 2026
·
9 min read
Press Releases
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
July 1, 2026
·
6 min read
Press Releases
Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical
July 1, 2026
·
5 min read
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
·
11 min read
1 of 88,514
Next
